Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-10.51 Mil
% of Total Estimate Gain
-48.48%

Board of Trustees of The Leland Stanford Junior University's BridgeBio Pharma Inc Holding Summary

As of 2025-03-31, Board of Trustees of The Leland Stanford Junior Un held - shares of BridgeBio Pharma Inc(BBIO), totaling N/A. This investment constitutes 0% of their stock portfolio, and Board of Trustees of The Leland Stanford Junior Un now holds 0% of the outstanding BridgeBio Pharma Inc(BBIO) stock.

The initial trade took place in 2021Q1. And since then Board of Trustees of The Leland Stanford Junior University has made 1 purchases of BBIO, at an average price of $65.45, for a total of 331,283.00 shares. In addition, there have been 1 sales at an average price of $33.72 for 331,283.00 shares. Based on historical transaction data and BBIO's current price of $43.99, Board of Trustees of The Leland Stanford Junior University's estimated gain on his BBIO holdings is $-10.51 Mil, reflecting a -48.48% gain to date.

Board of Trustees of The Leland Stanford Junior University BBIO ($43.99) Holding Chart

Board of Trustees of The Leland Stanford Junior University BBIO ($43.99) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1